転移性乳がん細胞は,DDX3-DRP1媒介によるミトコンドリアの可塑性による脂肪酸酸化抑制に脆弱である
Wen-Jing Hsu1, Ming-Chien Hsu1, Cheng-Ying Chu2
1Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan; Department of Biochemistry and Molecular Cell Biology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Redox biology
|August 29, 2025
まとめ
転移性乳がん細胞は,DDX3によって誘発される脂肪酸酸化 (FAO) とミトコンドリア分裂により,適応して広がります. このDDX3による代謝の脆弱性をターゲットにすることで,転移を抑制することができます.
科学分野:
- 腫瘍学
- 細胞生物学
- 代謝に関する研究
背景:
- 転移した腫瘍細胞は 新しい環境で生き残るための代謝の柔軟性を示します
- ミトコンドリアの生体生成とダイナミクスは腫瘍細胞のエネルギー需要と可塑性にとって重要です
- ミトコンドリア動態と腫瘍転移を結びつける正確な分子メカニズムは,まだ完全に理解されていません.
研究 の 目的:
- ミトコンドリアダイナミクスが乳がん転移に寄与する分子メカニズムを解明する.
- ミトコンドリア機能の調節と転移中の代謝適応におけるDEAD- boxポリペプチド3 (DDX3) の役割を調査する.
主な方法:
- 転移性乳がん細胞におけるミトコンドリアの脂質含量と脂肪酸酸化 (FAO) の分析
- ミトコンドリア分裂とFAOの調節におけるDDX3の役割の調査
- ミトコンドリア動態を媒介するDDX3,ダイナミン関連タンパク質1 (DRP1) とサイクリン依存キナーゼ1 (CDK1) の相互作用の検討.
- DDX3-DRP1-CDK1軸の抑制ががん幹と転移に与える影響の評価
主要な成果:
- 転移性乳がん細胞は,ミトコンドリアの脂質含有量増加と,ミトコンドリア分裂の強化と相まって,FAOへの代謝シフトを示しています.
- DDX3の上昇はミトコンドリアの分裂を促進し,FAOを容易にし,DDX3の抑制はFAOを減少させ,酸化ストレスを誘発する.
- DDX3はCDK1経由でS616でのDRP1リン酸化を媒介し,DDX3-DRP1-CDK1軸を形成する.
- この軸の阻害は癌の幹を減らし,腫瘍の転移を減少させます.
結論:
- DDX3はミトコンドリアの可塑性を調節し,乳がんの転移に代謝適応を促します.
- DDX3-DRP1-CDK1軸は,乳がんにおける代謝適応と転移の重要なレギュラーである.
- DDX3は,がんの代謝と転移に介入するための潜在的な診断バイオマーカーと治療目標です.
関連する概念動画
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K


